Cart
sales@molnova.com
SF5
CAS No. 34634-22-5
SF5( SF-5 | SF 5 | 2,2-Diphenylethylisothiocyanate )
Catalog No. M27794 CAS No. 34634-22-5
SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 25MG | 39 | In Stock |
|
| 50MG | 56 | In Stock |
|
| 100MG | 77 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 184 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSF5
-
NoteResearch use only, not for human use.
-
Brief DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
-
DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.(In Vitro):SF5 shows strong cell survival effect of kidney epithelial cells (93% at a concentration of 2.5 μM).
-
In Vitro——
-
In Vivo——
-
SynonymsSF-5 | SF 5 | 2,2-Diphenylethylisothiocyanate
-
PathwayApoptosis
-
TargetApoptosis
-
Recptorribonucleotide reductase(RR)|Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34634-22-5
-
Formula Weight239.34
-
Molecular FormulaC15H13NS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C=NCC(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Larsen IK, et al. Caracemide, a site-specific irreversible inhibitor of protein R1 of Escherichia coli ribonucleotide reductase. J Biol Chem. 1992 Jun 25;267(18):12627-31.
molnova catalog
related products
-
nor-NOHA acetate
nor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.
-
Targapremir-210
Targapremir-210 (TGP-210) is a selective and potent inhibitor of miRNA-210 (miRNA-210), which inhibits pre-miR-210 processing and induces apoptosis in breast cancer cells.
-
Tetrac
Tetrac (Tetraiodothyroacetic acid) is a derivative of L-thyroxine (T4), a thyroxine integrin receptor antagonist.Tetrac induces antiproliferation by blocking EGFR-mediated cell signaling in colorectal cancer cells.
